Related Experiment Video

Updated: Jan 29, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K

Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations

James A Spudich1,2

  • 1Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, 94305, USA. jspudich@stanford.edu.

Pflugers Archiv : European Journal of Physiology
|February 16, 2019
PubMed

Insights

Hypertrophic cardiomyopathy mutations cause heart hypercontractility by altering myosin function. Understanding these molecular changes is key to developing new treatments for this condition.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biophysics

Background:

  • Hypertrophic cardiomyopathy (HCM) is linked to mutations in human β-cardiac myosin.
  • These mutations are thought to cause heart hypercontractility, leading to cardiac issues.

Purpose of the Study:

  • To explore three molecular perspectives on how HCM mutations induce cardiac hypercontractility.
  • To discuss experimental approaches and potential therapeutic strategies for HCM.

Main Methods:

  • Analysis of the actin-activated β-cardiac myosin chemo-mechanical ATPase cycle.
  • Assessment of functionally accessible myosin heads in the sarcomere.
  • Investigation of load dependence of contractility and its alteration by mutations.

Main Results:

  • Perspective 1: Altered ATPase cycle parameters contribute to hypercontractility.
  • Perspective 2: Increased accessible myosin heads enhance cardiac contraction.
  • Perspective 3: Mutations affect load dependence, changing cardiac power output.

Conclusions:

  • HCM mutations induce hypercontractility through distinct molecular mechanisms.
  • Targeting these mechanisms offers potential therapeutic avenues for HCM treatment.

Keywords:
Hypertrophic cardiomyopathyInteracting heads motifLoadSuper-relaxed stateβ-Cardiac myosin

More Related Videos

Perspectives on Neuroscience26:41

Perspectives on Neuroscience

Published on: July 31, 2007

5.3K
Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.8K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
467
Mutations01:39

Mutations

Overview
94.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
549
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
519
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K